Fresenius Medical Care Q3 2024 Adj EPS €0.73 May Not Be Comparable To €0.35 Estimate, Sales €4.76B Miss €4.89B Estimate
Fresenius Medical Care Q3 2024 Adj EPS €0.73 May Not Be Comparable To €0.35 Estimate, Sales €4.76B Miss €4.89B Estimate
费森尤斯医疗2024年第三季度调整后每股收益为€0.73，可能无法与€0.35的预估相比，销售额为€47.6亿，低于€48.9亿的预估。
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.35 by 108.57 percent. This is a 28.07 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $4.76 billion which missed the analyst consensus estimate of $4.89 billion by 2.67 percent. This is a 3.57 percent decrease over sales of $4.94 billion the same period last year.
费森尤斯医疗（纽约证券交易所代码：FMS）公布的季度收益为每股0.73美元，比分析师普遍预期的0.35美元高出108.57％。这比去年同期每股收益0.57美元增长了28.07％。该公司公布的季度销售额为47.6亿美元，比分析师共识估计的48.9亿美元低2.67％。这比去年同期的49.4亿美元销售额下降了3.57％。
资讯热榜
更新时间